Journals / Türk Osteoporoz Dergisi / 2012 / Cilt: 18 - Sayı: 3

Prevalence of vitamin D deficiency and its relation with bone mineral density in HIV/AIDS patients

HIV/AIDS hastalarında D vitamini eksikliğinin sıklığı ve kemik mineral dansitesi ile ilişkisi

Pages
78–80
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Review of bone health should become part of routine care for all HIV- infected patients to prevent fractures.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In addition to immune regulation, vitamin D has the most important role in bone health.
📊
Key Findings & Data:Materials and Methods: Ninety-six HIV/AIDS patients were analyzed between April-November 2011.
💡
Conclusion & Impact:Review of bone health should become part of routine care for all HIV- infected patients to prevent fractures.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In addition to immune regulation, vitamin D has the most important role in bone health. We aimed to investigate the prevalence of vitamin D deficiency and its relation with bone mineral density (BMD) in HIV-infected patients. Materials and Methods: Ninety-six HIV/AIDS patients were analyzed between April-November 2011. Age, gender, antiretroviral treatment, CD4 cell count, HIV-RNA, BMD, 25(OH)D measurement of patients were collected retrospectively from medical records. Plasma 25(OH)D level was measured by chemiluminescence immunoassay and were assigned to be deficient, insufficient and sufficient, 50nmol/ml, respectively. The patients were diagnosed as osteopenic, osteoporotic or normal by dual energy x-ray absorptiometry measurements according to World Health Organization criteria. Analyses were performed using SPSS version 13.0. Results: Median age was 40.1 years (range, 20-70), 82% were male, mean plasma HIV-RNA was 5.2±1.0 log10 copies/ml and CD4 lymphocyte was 440.9±215.7/mm3, 80.2% were treated with antiretroviral agents. Of total 15% had deficient, 69% had insufficient 25(OH)D levels. Osteopenia and osteoporosis were diagnosed in 50% and 26%, respectively. No interrelation between osteopenia/osteoporosis and 25(OH)D levels was shown statistically (p=0.283). Conclusion: Whereas no interrelation between osteopenia+osteoporosis and 25(OH)D levels was shown statistically, vitamin D deficiency was twice more in osteopenia+osteoporosis group than in BMD normal group. Review of bone health should become part of routine care for all HIV- infected patients to prevent fractures.

Özet

Amaç: D vitamini, immün sistemdeki etkilerinin yanında kemik sağlığında önemli role sahiptir. Çalışmamızda HIV-enfekte hastalarda D vitamini eksikliğinin sıklığını ve kemik mineral dansitesi (KMD) ile ilişkisini araştırmayı amaçladık. Gereç ve Yöntemler: Nisan-Kasım 2011 tarihleri arasında polikliniğimize başvuran 96 HIV/AIDS hastası çalışma kapsamına alınmıştır. Olguların yaş, cinsiyet, antiretroviral ilaç kullanımı, KMD ölçümü, CD4+ lenfosit, HIV-RNA, 25(OH)D düzeyleri hasta dosyalarından retrospektif olarak incelenmiştir. Kemilüminesans immunoassay yöntemiyle serum 25(OH)D düzeyi 50 nmol/ml “normal” olarak kabul edilmiştir. Hastaların KMD’leri dual energy x-ray absorptiometry ile Dünya Sağlık Örgütü'nün kriterlerine göre T-score -2,5 ile -1 arasındakiler “osteopeni”, T-score

🔖

Cite This Article

AYDIN, Ö. A., KUMBASAR, H. K., KARAHASANOĞLU, R., KORKUSUZ, R., ERDOĞAN, Y. D., NAZLICAN, Ö. (2022). Prevalence of vitamin D deficiency and its relation with bone mineral density in HIV/AIDS patients. Türk Osteoporoz Dergisi, Cilt: 18 - Sayı: 3, 78–80. https://ajindex.com/articles/639883

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Bonjoch A, Figueras M, Estany C, Peres-Alverez N, Rosales J, del Rio L, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 2010;24(18):2827-33
  2. Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Philips AN, et al. Reduced bone mineral density in HIV-positive individuals. AIDS 2001;15:1731-33
  3. Brown TT, Ruppe MD, Kassner R, Kumar P Kehoe T, Dobs AS, et al., Reduced bone mineral density in human immunodeficiency virus- infected patients and its association with increased central adiposity and postload hyperglicemia. J Clin Endocrinol Metab 2004;89(3):1200-6
  4. Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P et al., Prevalence and risk factors for osteopenia/osteoporosis in an HIV- infected male population. Wien Klin Wochenschr 2007;119(21- 22):639-46
  5. Groger R, Erin Q, William P Osteoporosis in HIV-infected patients. Clinical rewievs in bone and mineral metabolism 2004;2(2):167- 73
  6. Yin M, Stein E. The Effect of Antiretrovirals on Vitamin D. Clin Infect Dis 2011;52(1):406-8
  7. Clinician’s Guideline to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation. January 2010. p. 6-15
  8. Ercan O. Ergenlik çağında kemik sağlığı. Türk Ped Arş 2011;46:54-8
  9. Holick MF Vitamin D Deficiency. N Eng J Med 2007;357:266-81
  10. Olmez D, Bober E, Buyukgebiz A, Cimrin D. The frequency of vitamin D insufficiency in healthy female adolescents. Acta Paediatr 2006;95:1266-9
  11. Akli T, Gulu S, Uysal AR, Erdogan G. The prevalence of vitamin D deficiency and effects of ultraviolet light on vitamin D levels in elderly Turkish population. Arch Gerontol Geriatr 2005;40:53-60
  12. Basaran S, Guzel R, Coskun-Benlidayi I, Guler-Uysal F Vitamin D. status:effects on quality of life in osteoporosis in among Turkish women. Qual Life Res 2007;16(9):1491-9. Epub 2007 Sep 9
  13. Lake JE, Adams JS. Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep 2011;8(3):133-41. doi: 10.1007/s11904-011-0082-8
  14. European AIDS Clinical Society Guidelines. Version 6- October 2011. p. 35
  15. Etminani-Esfahani M, Khalili H, Soleimani N, Jafari S, Abdollahi A, Khazaeipour Z, et al. Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr HIV Res 2012;10(2):165-70
  16. Crutchley RD, Gathe J Jr, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the South centr